David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
CALL
Danaher
DHR
$151B
| $7.2M | 0.01% |
33,840
-2,256
| -6% | -$478K |
|
1502
Emergent Biosolutions
EBS
$300M
| $7.19M | 0.01% |
977,917
-385,863
| -28% | -$3.58M |
|
1503
Mercury Insurance
MCY
$5.81B
| $7.18M | 0.01% |
237,285
-30,545
| -11% | -$932K |
|
1504
GE HealthCare
GEHC
$33.2B
| $7.18M | 0.01% |
88,401
-78,945
| -47% | -$6.3M |
|
1505
Xerox
XRX
$394M
| $7.18M | 0.01% |
482,281
+427,545
| +781% | +$6.26M |
|
1506
Delta Air Lines
DAL
$54.9B
| $7.18M | 0.01% |
151,012
-70,428
| -32% | -$2.6M |
|
1507
Concentrix
CNXC
$1.67B
| $7.17M | 0.01% |
88,754
+79,307
| +839% | +$7.42M |
|
1508
CALL
Intuit
INTU
$93.9B
| $7.15M | 0.01% |
15,600
-34,200
| -69% | -$15M |
|
1509
Weave Communications
WEAV
$584M
| $7.13M | 0.01% |
641,727
+593,833
| +1,240% | +$3.97M |
|
1510
CALL
Estee Lauder
EL
$38B
| $7.13M | 0.01% |
36,300
+24,100
| +198% | +$5.11M |
|
1511
Upbound Group
UPBD
$1.15B
| $7.12M | 0.01% |
228,767
-61,045
| -21% | -$1.78M |
|
1512
Williams-Sonoma
WSM
$27.8B
| $7.12M | 0.01% |
113,762
-105,078
| -48% | -$6.26M |
|
1513
Amphastar Pharmaceuticals
AMPH
$938M
| $7.1M | 0.01% |
123,599
-13,714
| -10% | -$608K |
|
1514
Maravai LifeSciences
MRVI
$1.33B
| $7.06M | 0.01% |
568,282
-582,061
| -51% | -$7.86M |
|
1515
PUT
Phillips 66
PSX
$96.8B
| $7.05M | 0.01% |
73,900
+52,000
| +237% | +$5.05M |
|
|
SGI
1516
Somnigroup International
SGI
$13.5B
| $7.04M | 0.01% |
175,809
-449,159
| -72% | -$16.9M |
|
1517
UMB Financial
UMBF
$10.9B
| $7.03M | 0.01% |
115,382
+28,777
| +33% | +$1.72M |
|
1518
PUT
Range Resources
RRC
$9.76B
| $7.03M | 0.01% |
239,000
+127,200
| +114% | +$3.46M |
|
|
SEE
1519
DELISTED
Sealed Air
SEE
| $7.02M | 0.01% |
175,562
-195,219
| -53% | -$8.3M |
|
1520
Atara Biotherapeutics
ATRA
$97.5M
| $7M | 0.01% |
173,973
+4,781
| +3% | +$270K |
|
|
RRAC
1521
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $7M | 0.01% |
652,602
+200,000
| +44% | +$2.12M |
|
1522
Telus
TU
$15.2B
| $6.98M | 0.01% |
+358,478
| New | +$7.22M |
|
|
UTAA
1523
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
| $6.97M | 0.01% |
659,784
+359,784
| +120% | +$3.78M |
|
1524
PUT
Transocean
RIG
$6.28B
| $6.96M | 0.01% |
992,200
+166,900
| +20% | +$1.03M |
|
1525
Brown-Forman Class B
BF.B
$12.8B
| $6.95M | 0.01% |
104,111
-25,998
| -20% | -$1.66M |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.